/Companies

Xenocor

Salt Lake City, US · Founded 2022 · Utah corporation · 6 known investors

Find your way into Xenocor

Sign up to see every warm intro you have to Xenocor

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Xenocor team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Xenocor is a company that has completed a Series A funding round; the investors page provides an investor deck but does not describe the company's product or business.

Founders & leadership

Xenocor was founded in 2022 by John Langell, Lane Brooks, and Dinesh Patel.

JLJohn Langell
John LangellCo-Founder and Board Member
LBLane Brooks
Lane BrooksCo-Founder & Chief Technology Officer
DPDinesh Patel
Dinesh PatelCo-Founder, acting CEO & Executive Chairman of the Board
CD
CHARLES DECOSTER IVChief Executive Officer and Board Director2022–2024Charles Decoster IV held CFO and CEO roles at a medical device company from concept through commercialization, and led investor relations and strategic planning functions across public companies and PE/VC-backed businesses in healthcare and other sectors.
TWTony Watson
Tony WatsonChief Operating OfficerTony Watson has more than 20 years of experience in medical device sales and commercial operations. He previously served as Chief Revenue Officer and President of the Practitioner Channel at Energy4Life, and holds an MBA from the University of Minnesota's Carlson School of Management.
SFSHAWN FOJTIK
SHAWN FOJTIKNamed on SEC filing
GB
GEORGE BARANNamed on SEC filing
MFMARK FOSTER
MARK FOSTERBoard MemberExecutive Officer, Director at Trice Medical
JHJIM HOGAN
JIM HOGANNamed on SEC filing
AW
ANTONY WATSONNamed on SEC filing

Investors · 6

Also in the syndicate · 6

Baranco InvestmentsBaranco Investments, Inc.Barvest VenturesBarvest Ventures, Inc.GenHenn Venture Fund IleadPatel Family Investments

Funding

SEC filings, press & company announcements

$15M disclosed across 2 rounds · 2021–2023

  • $10MSeries AApr 2023 · 3 sources

    GenHenn Venture Fund I (lead), Baranco Investments, Baranco Investments, Inc., Barvest Ventures, Barvest Ventures, Inc., Patel Family Investments

    Source ↗
▶$5MraisedMar 2023 · 89 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • SHAWN FOJTIKDirector
  • GEORGE BARANDirector
  • MARK FOSTERDirector
  • JIM HOGANDirector
  • ANTONY WATSONDirector
  • CHARLES DECOSTER IVExecutive Officer, Director
  • DINESH PATELDirector
Offering amount
$10M
Amount sold
$5M
Minimum investment
$12.5K
First sale
Aug 2021
Incorporated
Corporation, Utah, 2022
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 1

Companies working in the same space as Xenocor.

In the news

Frequently asked questions

What does Xenocor do?
Xenocor is a company that has completed a Series A funding round; the investors page provides an investor deck but does not describe the company's product or business.
Who founded Xenocor?
Xenocor was founded by John Langell, Lane Brooks, Dinesh Patel in 2022.
How much funding has Xenocor raised?
Xenocor has disclosed $15M raised across 2 rounds.
Where is Xenocor headquartered?
Xenocor is headquartered in Salt Lake City, US.